For research teamsHelp me find a study
Back to all studies
CompletedNCT01500694

Extended-release Guanfacine HCl (Intuniv, SPD503) for ADHD

This study is completed in France, in the United Kingdom, in Belgium, .... It is testing Extended-release Guanfacine HCl (Intuniv, SPD503) for ADHD.

ADHDDrugFrom 6 Years to 17 Years

The public registry lists this study as not currently recruiting. This page remains available for information. Check the official record for the latest status and explore other recruiting studies.

Explore recruiting studies on this topic

Then choose your country and confirm availability with each study site.

In plain English

Key information made simple

What is this study testing?

This study is testing whether Extended-release Guanfacine HCl (Intuniv, SPD503) may be useful for people experiencing ADHD.

What would participation involve?

Participants may receive Extended-release Guanfacine HCl (Intuniv, SPD503), attend study visits with the research team. The registry lists locations in Austria, in Belgium, and in France.

Who is it mainly for?

This study appears to be mainly for people with ADHD. Because it may involve minors, a parent or guardian may need to be involved.

What should you check before joining?

Ask about the dose, safety monitoring, and possible side effects, whether there is a comparison group, how many visits or travel steps are needed, what role parents or guardians have in the process.

Your next step

Check the study details

Check the official source, then confirm these points with the research team.

View official study record (opens in a new tab)

  • Recruitment and eligibility

    Is a site open, and who can take part?

  • Visits and time

    Where are visits, can any be remote, and how much time is needed?

  • Costs and support

    What costs, reimbursement or compensation apply?

Before joining

Questions to ask before joining

Study clarity

Things to check before joining

Study start dateStarted: March 20, 2012
Recruitment status
Completed
Enrollment listed in the registry
215
Sponsor
Shire
Sponsor type
Unknown or unclear
Study type
Drug
Intervention type
Medication / drug
Study phase
Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
Locations
France, United Kingdom, Belgium, ...
Age range
From 6 Years to 17 Years
Official registry ID
NCT01500694
Official title
A Phase 3, Open-label, Multicentre Study to Provide Access to Guanfacine Hydrochloride Extended-release for European Subjects With Attention-deficit/Hyperactivity Disorder (ADHD) Who Participated in Study SPD503-315 or SPD503-316

Check recruitment and locations

Recruitment checked against the registry by HopeStage on . Registry information can change. Always confirm availability with the research team.

View official study record (opens in a new tab)

The overall study status can differ from each site's status. Open a country to see its locations and their registry status.

Austria · 2 sites
  • Medizinische Universitat Graz Univ fur Kinder
    Graz
    Site status: Not listed — confirm with the team
  • Institut fur Psychosomatik
    Vienna
    Site status: Not listed — confirm with the team
Belgium · 4 sites
  • Universitaire Kinder-end Jeugdpsychatrie
    Hoboken
    Site status: Not listed — confirm with the team
  • Centre de Reference Neuropediatrique Multidisciplinaire
    Namur
    Site status: Not listed — confirm with the team
  • Huisartspraktijk Jaak Mortelmans
    Oostham
    Site status: Not listed — confirm with the team
  • Zlekenhuis Inkendaal Koninklijke Instelling v.z.w.
    Vlezenbeek
    Site status: Not listed — confirm with the team
France · 3 sites
  • Centre Hospitalier Universitaire Amiens
    Amiens, Picardie
    Site status: Not listed — confirm with the team
  • Centre Hospitalier Charles Perrens
    Bordeaux
    Site status: Not listed — confirm with the team
  • Hopital Gui de Chauliac
    Montpellier
    Site status: Not listed — confirm with the team
Germany · 13 sites
  • Dr. med. Andreas Mahler
    Achim
    Site status: Not listed — confirm with the team
  • Emovis GmbH
    Berlin
    Site status: Not listed — confirm with the team
  • Sozialpsychitrisches Zentrum
    Dorsten
    Site status: Not listed — confirm with the team
  • Klinik und Poliklinik fur Kinder-und Jugendpsychiatrie un psychotherapie
    Dresden
    Site status: Not listed — confirm with the team
  • Dr. med Walter Robert Otto
    Fulda
    Site status: Not listed — confirm with the team
  • Dr. med. Christian Wolff
    Hagen
    Site status: Not listed — confirm with the team
  • Dr. med Friedrich Kaiser
    Hamburg
    Site status: Not listed — confirm with the team
  • Institut fur Ganzheitliche Medizin und Wissenschaft GmbH
    Hüttenberg
    Site status: Not listed — confirm with the team
  • Friedrich Schiller Universitat Jena Klinik fur Kinder und Jugendpsychiatrie
    Jena
    Site status: Not listed — confirm with the team
  • Universitatsmedizin der Johannes-Gutenberg-Universitat
    Mainz
    Site status: Not listed — confirm with the team
  • Kinder-und Jugendpsychiatrische Praxis
    München
    Site status: Not listed — confirm with the team
  • Somni bene GmbH Institut fur Medizinische Forschung und Schlatmedizin
    Schwerin
    Site status: Not listed — confirm with the team
  • Universitatsklinik Ulm
    Ulm
    Site status: Not listed — confirm with the team
Ireland · 1 site
  • Our Lady's Children's Hospital
    Crumlin, Dublin
    Site status: Not listed — confirm with the team
Italy · 6 sites
  • Azienda Ospedaliero-Universitaria Policlinico-Vittorio
    Catania
    Site status: Not listed — confirm with the team
  • Azienda Ospedallera G Salvini - Ospedale Di Circolo de RHO
    Milan
    Site status: Not listed — confirm with the team
  • Azienda Ospedallera Fatebenefratelli
    Milan
    Site status: Not listed — confirm with the team
  • U.O di Neuropsichiatria Infantile
    Padova
    Site status: Not listed — confirm with the team
  • IRCCS Fondazione Stella Maris
    Pisa
    Site status: Not listed — confirm with the team
  • Ospedale Policlinico GB Rossi
    Verona
    Site status: Not listed — confirm with the team
Netherlands · 2 sites
  • Flevo Research
    Almere Stad
    Site status: Not listed — confirm with the team
  • Mondriaan Zorggroep
    Heerlen
    Site status: Not listed — confirm with the team
Poland · 5 sites
  • NZOZ Gdanskie Centrum Zdrowia
    Gdansk
    Site status: Not listed — confirm with the team
  • Centrum Badari Klinicznych House Sp. z.o.o.
    Gdansk
    Site status: Not listed — confirm with the team
  • Gabinet Psychiatrii Doroslych, Dzieci i Mlodziezy
    Torun
    Site status: Not listed — confirm with the team
  • Indywidualna Specjalisyczna Praktyka Lekarska
    Torun
    Site status: Not listed — confirm with the team
  • Contrum Neurospychiatrii Neuromed
    Wroclaw
    Site status: Not listed — confirm with the team
Romania · 3 sites
  • Spitalul Clinic de Urgenta pentru Copli
    Timișoara, Timiș County
    Site status: Not listed — confirm with the team
  • Spitalul Clinic de Psihiatrie
    Bucharest
    Site status: Not listed — confirm with the team
  • Spitalul Clinic de Psihiatrie Socoia
    Iași
    Site status: Not listed — confirm with the team
Spain · 7 sites
  • Hospital Mutua de Terrassa
    Terrassa, Barcelona
    Site status: Not listed — confirm with the team
  • Hospital Universitani Vall d'Hebron
    Barcelona
    Site status: Not listed — confirm with the team
  • Hospital Infanta Leonor, Servicio de Psiquiatria
    Madrid
    Site status: Not listed — confirm with the team
  • Hospital Fundacion Alcorcon
    Madrid
    Site status: Not listed — confirm with the team
  • Hospital Son Llatzer
    Palma de Mallorca
    Site status: Not listed — confirm with the team
  • Unidad de Salud Mental Infanto Juvenil
    Santander
    Site status: Not listed — confirm with the team
  • Instituto Valenciano de Neurologia Pediatrica
    Valencia
    Site status: Not listed — confirm with the team
Sweden · 1 site
  • Drottning Silvias Barnsjukhus
    Gothenburg
    Site status: Not listed — confirm with the team
Ukraine · 7 sites
  • Regional Clinical Psychiatric Hospital
    Donetsk
    Site status: Not listed — confirm with the team
  • Institute of Neurology, Psychiatry and Narcology
    Kharkiv
    Site status: Not listed — confirm with the team
  • Institute of Health Care for Children and Teenagers
    Kharkiv
    Site status: Not listed — confirm with the team
  • Lviv Regional Clinical Psychiatric Hospital
    Lviv
    Site status: Not listed — confirm with the team
  • Odesa Regional Psychoneurological Dispensary
    Odesa
    Site status: Not listed — confirm with the team
  • Poltava Regional Clinical Psychiatric Hospital
    Poltava
    Site status: Not listed — confirm with the team
  • Vinnitsya regional psychoneurological hospital
    Vinnytsia
    Site status: Not listed — confirm with the team
United Kingdom · 6 sites
  • Lister Hospital
    Stevenage, Herfordshire
    Site status: Not listed — confirm with the team
  • Queen Elizabeth II Hospital - Howlands
    Welwyn Garden City, Herfordshire
    Site status: Not listed — confirm with the team
  • Alder Hey Children's NHS Foundation Trust
    West Derby, Liverpool
    Site status: Not listed — confirm with the team
  • The Children's Centre
    Norwich
    Site status: Not listed — confirm with the team
  • Ryegate Children's Centre
    Sheffield
    Site status: Not listed — confirm with the team
  • Centenary House Child and Adolescent Mental Health Services
    Sheffield
    Site status: Not listed — confirm with the team

Ask HopeStage to help me review this study

This record does not confirm open recruitment. We can help you understand it and explore other studies.

Loading the security check...
Study ID: NCT01500694. We help you review the study, but cannot decide medical eligibility.
In practice

For you

Participation may contribute to research. Personal benefit is not guaranteed.

Ask the research team to explain the activities, time commitment, and follow-up involved.

Study sites are listed. Confirm the relevant site and any travel before making plans.

Important

Not medical advice

Information from public sources. Are you the study sponsor? Contact us to update this page: hi@hopestage.com

FAQ

Questions about this study

What is this study trying to understand?

This study is exploring medication or study treatment for people with adhd. Participants may complete study visits, assessments, or follow-up activities defined by the research team. Direct benefit is not guaranteed. The detailed objective is not always clearly listed in the public registry; the study team can confirm.

Does this study involve a medication?

This appears to be a medication / drug study involving Extended-release Guanfacine HCl (Intuniv, SPD503). Phase 3 studies are usually larger and aim to confirm effectiveness and safety in a broader group.

Who might this study be for?

This study may concern people with adhd; age range: From 6 Years to 17 Years. The criteria appear fairly broad, but you should not assume you are eligible. The study team must confirm diagnosis, age, exclusions, available locations, and next steps.

What would I likely need to do?

You may need to take a study treatment and have regular medical follow-up. The listed study locations suggest that at least part of participation may involve a physical site. Ask whether some steps can be done remotely.

What side effects, interactions, or treatment changes should I check?

If the study involves a medication, ask whether it is already approved, experimental, or being tested for a new use. Check possible side effects, interactions with current treatment, dose changes, monitoring, and what happens if you feel worse. For any mental health study, also ask who to contact if you feel worse, whether participation may affect current treatment, whether you can stop, and who confirms eligibility.

Will I need to travel or attend in-person visits?

The listed study locations suggest that at least part of participation may involve a physical site. Ask which sites are open, how many visits are expected, whether any steps can be done remotely, and whether travel costs or compensation are listed.

Who is behind this study?

This study is sponsored by Shire, which appears to be unknown or unclear. If available, it can be useful to check the sponsor website, collaborators, investigator affiliation, and the official registry before deciding. HopeStage does not judge the quality of a sponsor or researcher, but helps you identify what to verify.

Can I still join this study?

The public registry lists this study as not currently recruiting. This page remains available for information. Check the official record for the latest status and explore other recruiting studies.

Explore other studies

Want to find a study that may fit you better?

Answer a few simple questions to explore HopeStage studies by condition, country, and situation.

Find a study that may fit me
Related studies

Explore related studies

Other studies that may be relevant based on condition, country, or study type.